about
Guidance for the prevention and treatment of cancer-associated venous thromboembolismBleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.Controversies in the management of cancer-associated thrombosis.Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.Management of pregnancy associated venous-thromboembolism: a survey of practicesA survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illnessUsing an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded.Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis.Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis.Clinical decision rules in venous thromboembolism.Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis.Thromboprophylaxis in cancer patients.Treatment of cancer-associated thrombosis: perspectives on the use of novel oral anticoagulants.Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation.Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis.A Framework for Modeling Workflow Execution by an Interdisciplinary Healthcare Team.Expanding a First-Order Logic Mitigation Framework to Handle Multimorbid Patient Preferences.Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety.Cancer, atrial fibrillation, and stroke.Outcomes in a nurse-led peripherally inserted central catheter program: a retrospective cohort study.Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis.Management of venous thromboembolism in patients with glioma.Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.Venous thromboembolism and occult cancer: impact on clinical practice.Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.Managing challenging patients with venous thromboembolism: a practical, case-based approach.Validity of standard gamble estimated quality of life in acute venous thrombosis.Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.
P50
Q28069131-A866048B-8096-4A11-A34D-5047AC72983DQ30235553-4AA58239-3984-418C-9350-5AF7D8C9412CQ33373252-40431674-10D8-4FE1-8843-A3B44FB02BC4Q33436708-62E1D670-BFE0-4C56-8E5D-929707EC3D8AQ33436975-6A49096E-DD9E-43A4-8B80-153D8A51A74AQ33601589-C1DA4354-295C-4538-9F2C-5A17AF33351DQ33610047-81D951C1-7F84-4953-8E79-6FF7126C827FQ33789121-93A536B3-F0F5-40B7-B88C-2F048CD7C50BQ35114602-619D81CC-64BE-4EEE-8CE8-3B857DC2AABFQ36366944-9FDD77FD-8405-4A34-81BC-0C39FE4A782DQ36397594-3BA06456-195A-4A11-BE14-26B63CE1C48DQ37075924-09B53423-D358-4FF1-AF64-0821E6164753Q37310820-6CD71DD9-84B4-4783-9816-4FBB240FE9EDQ37741638-7FBD3B31-2F9D-46EA-8FB7-3FFB5C00BA38Q37855094-BA74F3CB-43CB-482F-947B-0FE70CFD9672Q38041798-B13D304A-D1C8-48E3-B106-1C4C75A773B8Q38133389-B6654169-7D9F-4E7C-BA9E-5576CAF9B18EQ38137457-E2ECFFD7-6315-4B98-9FAE-C7EEB6524905Q38181777-9C62553D-09F4-4557-9F38-EE9C949496BDQ38186399-78F50B85-34EF-4E63-9114-0E22C12CC62CQ38193710-F6695A62-79E0-4FD0-AB2F-951C4EEC52B6Q38214961-5DBC9388-83BD-4C54-91E2-147A91BB14F8Q38217011-D34324EA-3BF0-44FE-9AA7-797F92A812B3Q38250112-8D256F1C-3BAA-4CC7-BA85-0A7589F32180Q38279947-A3D3531F-5990-4D31-9317-AEF9C008C8DDQ38406139-82339C5D-7B64-4E3D-8380-9E3F0029D956Q38614564-4EB1A0A3-E6DE-4600-BB56-C082062427D4Q38614845-28972985-DD12-4D67-B2B6-292E887ABA5CQ38633482-6F39152F-5326-4DE1-A689-1E7C947D89D8Q38681404-8049E3C4-694F-44C9-919D-E54C4EDB4E7AQ38693906-C54AAC7B-27EC-426C-91AD-E0E0BC97778CQ38716638-7580E04D-2CA8-4246-8620-84F23BE59265Q38720931-7F584C54-54A4-47B4-9F94-88C413BB7600Q38740028-DC0E1A73-85C7-4DAA-A027-B7C11430F54CQ38805438-E3FA9DF7-7EBF-493F-B362-00D32E3342BEQ38979421-B3561FF8-665E-4F0D-9C3C-61F1969DD216Q39066265-799F7C5F-8EE1-4569-ADEF-58A7F793E78AQ39079521-B07668B2-DF48-4711-9AA5-207A7B251E8FQ39137251-084A7C3A-C3C4-4747-BD6C-2A0407972DB5Q39214027-9BACEA48-1A78-4649-BC9F-0782D8E973C5
P50
name
Marc Carrier
@en
Marc Carrier
@nl
type
label
Marc Carrier
@en
Marc Carrier
@nl
prefLabel
Marc Carrier
@en
Marc Carrier
@nl